Thomas Wölfel

8.2k total citations · 3 hit papers
70 papers, 6.4k citations indexed

About

Thomas Wölfel is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Thomas Wölfel has authored 70 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Immunology, 26 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Thomas Wölfel's work include Immunotherapy and Immune Responses (53 papers), T-cell and B-cell Immunology (32 papers) and Immune Cell Function and Interaction (21 papers). Thomas Wölfel is often cited by papers focused on Immunotherapy and Immune Responses (53 papers), T-cell and B-cell Immunology (32 papers) and Immune Cell Function and Interaction (21 papers). Thomas Wölfel collaborates with scholars based in Germany, Belgium and United States. Thomas Wölfel's co-authors include Thierry Boon, Aline Van Pel, Vincent Brichard, Etienne De Plaen, Catherine Wölfel, Karl‐Hermann Meyer zum Büschenfelde, Jörg Schneider, Pierre G. Coulie, Bernard Lethé and Volker Lennerz and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas Wölfel

68 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A p16 ^INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma

1995 900 citations Thomas Wölfel, Jörg Schneider et al. profile →
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

1993 785 citations Vincent Brichard, Aline Van Pel et al. The Journal of Experimental Medicine profile →
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

1994 767 citations Pierre G. Coulie, Vincent Brichard et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Wölfel Germany	32	5.1k	2.8k	2.8k	612	438	70	6.4k
Mona El‐Gamil United States	29	4.4k 0.9×	4.0k 1.4×	2.8k 1.0×	481 0.8×	938 2.1×	41	6.6k
Bernard Lethé Belgium	28	5.0k 1.0×	2.1k 0.7×	3.1k 1.1×	465 0.8×	466 1.1×	39	6.0k
John R. Yannelli United States	34	5.5k 1.1×	3.6k 1.3×	2.2k 0.8×	597 1.0×	793 1.8×	74	7.3k
Danielle Líénard Switzerland	47	5.3k 1.0×	3.3k 1.1×	2.4k 0.9×	394 0.6×	380 0.9×	89	7.1k
Hyam I. Levitsky United States	39	6.7k 1.3×	3.7k 1.3×	1.9k 0.7×	392 0.6×	902 2.1×	65	8.3k
Roberta Mortarini Italy	40	2.9k 0.6×	2.0k 0.7×	2.1k 0.8×	341 0.6×	316 0.7×	100	4.9k
Immanuel F. Luescher Switzerland	42	6.1k 1.2×	2.9k 1.0×	1.8k 0.7×	735 1.2×	260 0.6×	132	7.2k
Christophe Lurquin Belgium	32	7.3k 1.4×	3.3k 1.2×	4.7k 1.7×	764 1.2×	785 1.8×	45	8.9k
Lea Eisenbach Israel	33	2.5k 0.5×	1.5k 0.5×	2.1k 0.8×	427 0.7×	570 1.3×	123	4.4k
Michael S. Krangel United States	54	6.3k 1.2×	1.8k 0.6×	3.4k 1.2×	1.4k 2.3×	556 1.3×	136	8.8k

Countries citing papers authored by Thomas Wölfel

Since Specialization

Citations

This map shows the geographic impact of Thomas Wölfel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wölfel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wölfel more than expected).

Fields of papers citing papers by Thomas Wölfel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Wölfel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wölfel. The network helps show where Thomas Wölfel may publish in the future.

Co-authorship network of co-authors of Thomas Wölfel

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wölfel. A scholar is included among the top collaborators of Thomas Wölfel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wölfel. Thomas Wölfel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Volkmar, Michael, Elham Fakhr, Rienk Offringa, et al.. (2023). Identification of TRDV-TRAJ V domains in human and mouse T-cell receptor repertoires. Frontiers in Immunology. 14. 1286688–1286688. 1 indexed citations

Fatho, Martina, Volker Lennerz, Annette Paschen, et al.. (2023). Targeting the melanoma-associated antigen CSPG4 with HLA-C*07:01-restricted T-cell receptors. Frontiers in Immunology. 14. 1245559–1245559. 2 indexed citations

Fatho, Martina, Michael Volkmar, Roland Conradi, et al.. (2020). A bicistronic vector backbone for rapid seamless cloning and chimerization of αβT-cell receptor sequences. PLoS ONE. 15(9). e0238875–e0238875. 4 indexed citations

Schadmand‐Fischer, Simin, Andreas Schwarting, Daniel Teschner, et al.. (2020). Life-threatening disseminated enterovirus infection during combined rituximab and ibrutinib maintenance treatment for mantle cell lymphoma: a case report. Journal of Medical Case Reports. 14(1). 135–135. 3 indexed citations

Zhao, Fang, Antje Sucker, Susanne Horn, et al.. (2016). Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency. Cancer Research. 76(15). 4347–4358. 57 indexed citations

Pritchard, Antonia L., Julie G. Burel, Michelle A. Neller, et al.. (2015). Exome Sequencing to Predict Neoantigens in Melanoma. Cancer Immunology Research. 3(9). 992–998. 45 indexed citations

Wölfel, Catherine, Sylvia Köhler, Marion Nonn, et al.. (2008). Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8+ CD62L(high)+ T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rγnull mice. Experimental Hematology. 36(4). 451–463. 21 indexed citations

Meyer, Ralf G., Claudine Graf, Cedrik M. Britten, Christoph Huber, & Thomas Wölfel. (2007). Rapid identification of an HLA-B*1501-restricted vaccinia peptide antigen. Vaccine. 25(24). 4715–4722. 3 indexed citations

Zhang, Yi, Zhaojun Sun, Hugues J. M. Nicolay, et al.. (2005). Monitoring of Anti-Vaccine CD4 T Cell Frequencies in Melanoma Patients Vaccinated with a MAGE-3 Protein. The Journal of Immunology. 174(4). 2404–2411. 26 indexed citations

10.

Britten, Cedrik M., et al.. (2004). The use of clonal mRNA as an antigenic format for the detection of antigen-specific T lymphocytes in IFN-γ ELISPOT assays. Journal of Immunological Methods. 287(1-2). 125–136. 15 indexed citations

11.

Britten, Cedrik M., et al.. (2002). The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8+ T lymphocytes in IFN-γ ELISPOT assays. Journal of Immunological Methods. 259(1-2). 95–110. 105 indexed citations

12.

Staege, Martin S., Jörg Schneider, Manfred Eulitz, et al.. (2000). Consequences of Antigen Self-Presentation by Tumor-Specific Cytotoxic T Cells. Immunobiology. 201(3-4). 332–346. 7 indexed citations

13.

Herr, Wolfgang, Ulrike Protzer, Ansgar W. Lohse, et al.. (1998). Quantification of CD8⁺T Lymphocytes Responsive to Human Immunodeficiency Virus (HIV) Peptide Antigens in HIV‐Infected Patients and Seronegative Persons at High Risk for Recent HIV Exposure. The Journal of Infectious Diseases. 178(1). 260–265. 45 indexed citations

14.

Herr, Wolfgang, et al.. (1997). The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor α spots in response to peptide antigens. Journal of Immunological Methods. 203(2). 141–152. 120 indexed citations

15.

Skipper, Jonathan, Ronald C. Hendrickson, Pamela H. Gulden, et al.. (1996). An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.. The Journal of Experimental Medicine. 183(2). 527–534. 346 indexed citations

16.

Wölfel, Thomas, Aline Van Pel, Vincent Brichard, et al.. (1994). Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes. European Journal of Immunology. 24(3). 759–764. 345 indexed citations

17.

Heike, Michael, et al.. (1994). Membranes Activate Tumor- and Virus-Specific Precursor Cytotoxic T Lymphocytes In Vivo and Stimulate Tumor-Specific T Lymphocytes In Vitro. Journal of Immunotherapy. 15(3). 165–174. 15 indexed citations

18.

Coulie, Pierre G., P. Weynants, Frédéric Lehmann, et al.. (1993). Genes Coding for Tumor Antigens Recognized by Human Cytolytic T Lymphocytes. Journal of Immunotherapy. 14(2). 104–109. 42 indexed citations

19.

Boon, Thierry, Jean‐Pierre Szikora, Etienne De Plaen, Thomas Wölfel, & Aline Van Pel. (1989). Cloning and characterization of genes coding for tum− transplantation antigens. Journal of Autoimmunity. 2. 109–114. 4 indexed citations

20.

Knuth, Alexander, et al.. (1989). Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.. Proceedings of the National Academy of Sciences. 86(8). 2804–2808. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact